Gem-doce and BCG yield similar outcomes for upper tract urothelial cell carcinoma
May 1st 2024"Ultimately, we found that in this retrospective evaluation, there was no significant difference in recurrence-free survival in those who are treated with gemcitabine and docetaxel as compared to BCG," says Ryan L. Steinberg, MD.
Expert on future directions for targeted therapy in urothelial carcinoma
April 30th 2024“There is great interest in looking at all these targeted interventions in the earlier stages to lower the burden of care that patients go through and to some degree that urologists and other health care professionals in this in this realm go through,” says Surena F. Matin, MD.
ADT/ARPI/radiotherapy combo appears efficacious in mHSPC
April 21st 2024"Prostate radiotherapy is obviously widely available, inexpensive, generally [with] a mild toxicity profile. So I think it's a reasonable option in that scenario in patients who present with de novo low-volume disease," says , Scott Morgan, MD, MSc, FRCPC.
Future work in urology may look at factors influencing pursuit of the field
April 18th 2024"We can also look at the timing of exposure to urology. Does early exposure spark interest in urology, or does delayed introduction to the field hinder the consideration of the specialty?" says Ashley Appleton.
Expert discusses meta-analysis of prostate radiotherapy
April 18th 2024"In my view, at present in patients that have low-volume oligometastatic de novo metastatic prostate cancer, it's really an unknown whether comprehensive SBRT or other local therapy directed at oligomets improves survival," says Scott Morgan, MD, MSc, FRCPC.
Dr. Salari on family history, germline genetic risk in favorable-risk prostate cancer
April 16th 2024"What we found is that over a third of patients, 36%, had positive family history of either prostate, breast, or pancreatic cancer. And if you had this type of a family history, there was nearly a two-fold risk of dying of prostate cancer in the long term," says Keyan Salari, MD, PhD.
Study highlights need to recruit and retain URiM urologists
April 12th 2024"At the medical student level, we can provide early exposure to urology to make sure that these students feel properly equipped to apply to urology when that time comes and get adequate exposure to the field," says Ashley Appleton.
Dr. Morgan discusses guideline for salvage therapy in prostate cancer
April 11th 2024"There have been some pivotal clinical trials that have reported out, and they've really showed us that there is limited to maybe no role for adjuvant treatment after prostatectomy, and there is a huge role for early salvage treatment," says Todd M. Morgan, MD.